Losing definition: the global debate over 'counterfeit' drugs
As Kenya moves to implement its controversial Anti-counterfeit Act, which effectively outlaws generic drugs, WTR examines the problem with the term 'counterfeit medicine' and why it troubles brand owners around the world.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the WTR experts.